These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The use of pharmacy personnel to positively impact hospital finances. Hutchinson RA; Hatoum HT; Kolinski R; Riley DW Hosp Formul; 1989 Aug; 24(8):450, 453. PubMed ID: 10294357 [TBL] [Abstract][Full Text] [Related]
25. WILL "PROFESSIONAL FEE" SYSTEM BE CHARGING SYSTEM OF FUTURE? BOWLES GC Mod Hosp; 1963 Sep; 101():178. PubMed ID: 14049059 [No Abstract] [Full Text] [Related]
26. Case-control analysis of the financial cost of medication errors in hospitalized patients. Pinilla J; Murillo C; Carrasco G; Humet C Eur J Health Econ; 2006 Mar; 7(1):66-71. PubMed ID: 16369841 [TBL] [Abstract][Full Text] [Related]
27. Editorial: Economics of drug brand standardization by hospitals. Zellmer WA Am J Hosp Pharm; 1975 Dec; 32(12):1232. PubMed ID: 1211396 [No Abstract] [Full Text] [Related]
28. Analyzing and predicting hospital pharmacy costs using stepwise regression. Naylor MJ; Tester WW Am J Hosp Pharm; 1971 Mar; 28(3):162-71. PubMed ID: 5563686 [No Abstract] [Full Text] [Related]
29. Comment on "Analysing and predicting hospital pharmacy costs using stepwise regression". Gibson JT Am J Hosp Pharm; 1972 Jan; 29(1):29-30. PubMed ID: 5021508 [No Abstract] [Full Text] [Related]
30. Using the business plan to propose revenue-generating pharmacy services. Schneller LW; Powell MF; Solomon DK Hosp Pharm; 1988 Sep; 23(9):806-8, 809-11. PubMed ID: 10302758 [TBL] [Abstract][Full Text] [Related]
31. Establishing a fee for handling investigational drug studies. Ngu BQ; Schneider PJ; Kilarski DJ Am J Hosp Pharm; 1982 Aug; 39(8):1308-10. PubMed ID: 7124750 [TBL] [Abstract][Full Text] [Related]
33. What types of services are conducive to lower pharmacy costs for non-profit hospitals? Gordon PA Hosp Forum; 1976 Jul; 19(2):23-4. PubMed ID: 10242068 [No Abstract] [Full Text] [Related]
34. [Analysis of the hospital maintenance cost]. Gusev OA Sov Zdravookhr; 1974; 33(4):17-23. PubMed ID: 4276794 [No Abstract] [Full Text] [Related]
35. Professional fees for pharmacists. ARCHAMBAULT GF Hosp Prog; 1963 Feb; 44():128-44. PubMed ID: 14013611 [No Abstract] [Full Text] [Related]
36. [Analysis of expenditures in the Perm district hospital, as based on article 10 of the estimate]. Selezneva VT; Seklitskaia AM; Bushueva NF Zdravookhr Ross Fed; 1976 Sep; (9):40-2. PubMed ID: 136155 [No Abstract] [Full Text] [Related]
37. [Various problems of economics and work organization of the Kemerovo District Hospital]. Skladchikova EN Zdravookhr Ross Fed; 1973 Mar; 17(3):5-8. PubMed ID: 4493679 [No Abstract] [Full Text] [Related]
38. Fee structure for investigational drug studies. Anandan JV; Isopi MJ; Warren AJ Am J Hosp Pharm; 1993 Nov; 50(11):2339-43. PubMed ID: 8266958 [TBL] [Abstract][Full Text] [Related]
39. Economic evaluations of clinical pharmacy services--1988-1995. The Publications Committee of the American College of Clinical Pharmacy. Schumock GT; Meek PD; Ploetz PA; Vermeulen LC Pharmacotherapy; 1996; 16(6):1188-208. PubMed ID: 8947994 [TBL] [Abstract][Full Text] [Related]
40. Impact of parenteral cephalosporin regulation on pharmacy costs. Ryan JL; Francese J Hosp Formul; 1983 May; 18(5):510-2. PubMed ID: 10260198 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]